Early Access — free while we kick the tires
EdgarHawk

Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Director Officer
1 filing analyzed · 1 company · Latest 2025-05-27

Companies

Company Buys Sells Direction
Compass Therapeutics, Inc. CMPX 1 0 Net buying

Activity

May 2025
medium
Buy
10,000 shares
$21,100
Significance 4/10

CEO Thomas J. Schuetz buys 10,000 shares of CMPX at $2.11; now holds 6.48M shares total.

CEO Thomas J. Schuetz purchased 10,000 shares at $2.11, bringing his total holdings to 6,480,825 shares. The company generated zero revenue in its latest quarter and reported a net loss of $-16,633,000.00, with negative full-year profitability. The stock has declined 45.9% from its 52-week high of $3.90 but is up 8.8% over the last 30 days. The purchase represents a modest addition (0.2% of pre-transaction holdings) that, while consistent with insider engagement, occurs within a context of negative earnings and cash burn that investors should monitor closely.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access